---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-027158"
form_type: "8-K"
ticker: "ANEB"
cik: "0001815974"
company_name: "Anebulo Pharmaceuticals, Inc."
filed_at: "2022-09-29T23:59:59+00:00"
generated_at: "2026-06-23T06:47:11.747580+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Anebulo raises $6.6M in private placement of common shares and warrants

## Summary
- Sold 2,264,650 units at $2.935 each for aggregate proceeds of ~$6.6 million; each unit consists of one share and one warrant.
- Warrants exercisable at $4.215 per share, immediately exercisable, five-year term; beneficial ownership limitation applies.
- 22NW Fund, LP, an affiliate of director Aron English, purchased 1,703,577 units for ~$5.0 million.
- Net proceeds to advance development of ANEB-001 (acute cannabinoid intoxication) and for general corporate purposes.
- MTS Securities acted as placement agent; fee of 6% of gross proceeds (1% for 22NW participation) plus expenses.

## SEC filing metadata
- accession: 0001493152-22-027158
- form_type: 8-K
- ticker: ANEB
- cik: 0001815974
- company_name: Anebulo Pharmaceuticals, Inc.
- filed_at: 2022-09-29T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1815974/000149315222027158/0001493152-22-027158-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1815974/000149315222027158/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-027158
- JSON: https://secwatch.observer/filing/0001493152-22-027158.json
- Plain text: https://secwatch.observer/filing/0001493152-22-027158.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.